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Abstract  
The objective of this paper is to describe genes expression patterns of the anti-apoptotic Bcl2 and pro apoptotic 
Bax as well as EBV infection marker LMP1 in, leiomyoma tissue according to patients vitamin D status. To 
investigate the relationship between alterations of genes expression patterns and serum vitamin D levels, 
samples from 105 women undergoing surgery for uterine leiomyoma in 6 hospitals in Kinshasa from April 1 to 
October 31, 2014 were obtained for genes expression analysis of Bcl-2, Bax and LMP-1 genes. Genes 
expression in leiomyomas was measured by immunohistochemistry. Serum vitamin D levels were determined 
by IRMA. Association between vitamin D status and genes expression was assessed using logistic regression 
analysis. From 105 women providers of leiomyoma tissues examined, 41 were sufficients in vitamin D, 36 were 
insufficients and 28 deficients. In uterine leiomyoma tissues obtained Bcl2 was expressed in 96 (91.4%) of 
samples with low, moderate and high expression observed in 33.3%, 32.4% and 25.7%, respectively. The 
differences in Bcl2 expression between the three subgroups of vitamin D categories were not statistically 
significant. 
------------------------------------------------------------------------ 
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As a mirror of Bcl2 expression, Bax protein was not expressed in the majority (n = 95, 90.5%) of samples. 
Similar to Bcl2, the differences in Bax expression between the three subgroups of vitamin D categories did not 
reach the level of statistical significance. Of the 105 leiomyoma tissue examined, LMP1 was observed in 30 
(28.6%) of samples and showed a tendency towards increased expression with the decline in vitamin D levels; 
however, the tendency was fairly not statistically significant. 
In multivariate analysis, predictors of Bcl2 expression were age, parity, and overweight/obesity and 
insufficiency/deficiency vitamin D; however, the differences observed were not statistically significant. The 
same predictors were also associated with Bax expression but once again the observed differences were not 
statistically significant. Vitamin D deficiency, the only predictor significantly associated with LMP1 expression, 
conferred a 3.9 fold greater risk (aOR 3.9; 95% CI 1.068-14.242; p = 0.039) of expressing LMP1 in leiomyoma 
tissue.  
In the present study, Bcl2 gene expression in ULM tissues tended to increase with the decline in vitamin D 
levels but observed differences were not statistically significant. In contrast, LMP1 gene expression was 
significantly associated with vitamin D deficiency. In spite of methodological limits, these findings do suggest a 
role of Vitamin D deficiency in the development and progression of ULM. 
Keys words: Bcl 2; Bax; and LMP1 genes expression; Uterine leiomyoma tissue; vitamin D status. 
1. Introduction 
Uterine leiomyomas (ULM) are the most common benign tumors of the female genital tract resulting in 
menstrual abnormalities, recurrent pregnancy loss and other serious gynecological disorders [1]. They are 3-4 
higher in black women than in white women [2] and occur in 20-25% of premenopausal women [3, 4]. Indeed, 
ULM have been reported to appear at the start of the reproductive age, grow under the influence of sex steroids 
and regress after menopause indicating the ovarian steroid-dependent growth potential [2]. Sex steroids estrogen 
and progesterone are thought to lead to tumor by stimulating a modest rate of cellular proliferation and the 
production of high amounts of extracellular matrix (ECM) proteins mainly collagen [5]. Although the role of 
steroids sex hormones estrogen and progesterone remain incompletely understood, the neoplastic transformation 
of a myocyte is likely due to some sort of cellular insult, although the exact etiology of this transforming event 
is currently unknown. Among potential cellular insults, viral infection by cytomegalovirus (CMV) and Epstein 
Barr virus (EBV) has been the focus of several studies [6, 7]. An association between latent membrane protein-1 
(LMP-1), a marker of EBV infection [8] and breast cancer as well as leiomyosarcomas of some soft tissues in 
immunocompromised young people [9] has been already found. The transformation of uterine smooth muscle 
cells to leiomyomas has been reported to probably involve somatic mutations of genes playing roles in 
proliferation and apoptosis in a normal myometrium and in complex interactions between sex steroids and 
growth factors [4]. With regards to apoptosis, ULM are associated with altered apoptosis by overexpression of 
the anti-apoptotic protein Bcl2 or by decreased expression of the pro-apoptotic protein Bax [10].  
The mainstay treatment option of ULM is surgery, in the form of myomectomy or hysterectomy [11]. However, 
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these procedures can be associated with substantial morbidity and mortality [11]. Therefore, it appears rationale 
to search for novel nonsurgical alternatives for the management of symptomatic ULM. In this regard, apart from 
GnRH agonists, aromatase inhibitors and selective-progesterone receptor modulators (SPRMs), there is 
encouraging research on the role of supplements such as vitamin D as potential treatment for ULM [12]. Recent 
clinical evidence indicates an association between serum vitamin D deficiency and increased risk of ULM [13, 
14, 15]. Furthermore, many experimental studies showed vitamin D to exert anti-proliferative effects on ULM 
cells through the reduction of the expression of cell proliferation markers proliferating cell nuclear antigen 
(PCNA), cyclin dependent kinase-1 (CDK-1) and Ki67 nuclear antigen [16]. Vitamin D also reduces the 
expression of the anti-apoptotic proteins Bcl2 and Bcl 2I1 [Bcl-X] [16]. Vitamin D has been also reported to 
reduce the expression of estrogen receptor (ER) [17]. In addition, vitamin D deficiency, a known immune 
dysfunction risk factor, could promote viral infection that can trigger neoplastic myocyte transformation [18]. 
In Democratic Republic of the Congo (DRC), ULM are commonly seen in gynecological daily practice and 
remain one the most common causes of hysterectomy and subsequent infertility [19]. Despite recent evidence on 
the role abnormal vitamin D homeostasis and ULM, no study has evaluated the relationship between vitamin D 
status and ULM cells expression of markers of apoptosis and EBV infection. Therefore, the aim of the present 
study was to assess the relationship, if any, between serum vitamin D status and expression of markers of 
apoptosis and EBV infection in uterus removed from women with ULM in clinical settings in Kinshasa, 
Democratic Republic of the Congo. 
2. Material et methods 
The study protocol was approved by the Ethical Committee of Kinshasa School of Public Health, University of 
Kinshasa (ESP/CE/028/2013).  
Clinical data  
 In total, 105 leiomyoma tissue samples and blood samples were obtained from 105 women undergoing surgery 
for uterine leiomyoma in 6 hospitals in Kinshasa from April 1 to October 31, 2014 to study gene expression of 
Bcl-2, Bax and LMP-1. Gene expression in leiomyomas was measured by immunohistochemistry. Serum 
vitamin D levels were determined by IRMA. Clinical parameters (age, parity, and menstrual cycle, personal 
history of uterine leiomyoma (ULM), hypertension, diabetes mellitus, and body mass index(BMI) were 
retrieved from medical chats of patients. 
The size (m) and the weight (kg) have been measured by a weights sick with spacer .The results obtained 
allowed the obtaining of the body mass index of each woman made by the report: weight(kg)/size (m)². 
The overweight and obesity have been defined respectively by BMI ≥25 kg/m² and >29.9 kg/( m)2. The two 
states have been considered as excess weight. 
 Vitamin D measurement 
10 ml of blood were collected from each patient before surgery act for the determination of vitamin D status . 
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The tubes of blood collected were protected from the light and then centrifuged at 2500 revolutions during 
10minutes after coagulation. Serum obtained after this centrifugation was kept at -20°C in the Regional 
Center in nuclear energy at the University of Kinshasa .The evaluation of the Vitamin D has been carried out by 
the radio immunological method (IRMA) (20). 
With the method IRMA, vitamin D contained in the serum of each patient was first captured by a poly clonal 
antibody. Then the vitamin D captured has then reacted with a commercial mono clonal antibody coupled to the 
Iodine 125 for its revelation. The amount of vitamin D that is obtained is proportional to the radio activity 
recorded by the gamma counter.               
In agreement with the local values of the vitamin D, the results obtained were enrolled in the three tranches 
below: sufficiency (≥15ng/ml), insufficiency deficit (4-14 ng/ml) and deficiency (˂ 4 ng/ml).  
Histopathology 
A levy biopsy, on the fabric of ULM, has been carried out at each made during the course of the procedure. The 
samples were then fixed to the buffered formalin and routed on the same day to the laboratory for pathology 
anatomy of the Faculty of Medicine of the University of Kinshasa for analysis.  
A histopathological analysis was conducted on each of these levies to confirm or refute the diagnosis of uterine 
leiomyomas. For its realization the fabrics have been treated in six following successive stages: macroscopy 
external and internal; Dehydration successively in the alcohol at 100°, then in the xylol; Coating for obtaining 
paraffin blocks with fabrics biopsies; cut paraffin blocks to the microtome in strips of 2 to 3μ thickness and 
construction of blades; coloring with haematoxylin and eosin; and mounting of the blades.  
The reading of the blades was then made within 15 minutes using the microscope ocular bi Leica brand DMRB 
with digital camera DCM integrated 900 (9 m pixel). 
Immunohistochemistry 
Immunohistochemical analysis was also made using paraffin blocks already availables. The analysis focused on 
the evaluation of the expression of proteins Ki 67, Bcl-2, Bax, and LMP1.Each block has allowed the 
construction of four blades of immunohistochemistry corresponding to the four proteins to assess. The blades 
were then kept in an oven for 24 hours at 56°C before to undergo the dewaxd. Blades have then suffered 
the pre EDTA treatment then marking: the first marking, the antigens on the blades have reacted with 100 µl of 
primary poly clonal antibody. The second marking, blades have reacted with the secondary mono clonal 
antibody. Each blade was then submitted to a chromogenic, DAB and then to a counter coloration with 
haematoxylin. 
The reading of the blades has been made by the microscope ocular Leica brand DMRB with digital camera 
DCM integrated 900 (9M pixel). The expression of the protein Ki 67 was sought in the cell nucleus. The 
expression of Bcl-2, and Bax were sought in the cell cytoplasm and that of LMP1 at membrane. The expression 
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was either positive or negative. In the case of positivity three levels were differenced: low expression 
(expression < 10%); moderate expression (expression, 10% to 30%); high expression (expression > 30%).The 
following table shows the different mono clonal antibodies used to test expressions of proteins Bcl-2, Bax, 
Ki 67, and LMP1           
Table 1: Mono clonal antibodies anti Bcl 2, Bax and LMP1 
ANTIBODY CLONE TARGET PRE 
TRAITEMENT 
DILUTION 
Ki67 SP6/MM 
FRANCE 
Nuclear CITRATE 
(pH : 6) 
1/300 
LMP1 MRQ-19/MM 
FRANCE 
Membranaire CITRATE 
(pH : 6) 
1/100 
Bcl-2 100/D5/MM 
FRANCE 
Cytoplasmic CITRATE 
(pH : 6) 
1/100 
Bax 2D2/MM 
FRANCE 
Cytoplasmic CITRATE 
(pH : 6) 
1/100 
 
Statistical analysis                                                                                                    
SPSS for Windows version 21.0 was used to perform the statistical analysis of the data.  Normally distributed 
and skewed continuous variables were expressed as mean ± SD or median (range), respectively. Patients were 
divided in three categories according to vitamin D status: sufficiency, insufficiency and deficiency. Comparison 
of normally distributed and skewed variables between the three subgroups were made using one ANOVA and 
Kruskall Wallis, respectively; for the comparison of categorical variables, chi square test was used. Logistic 
regression analysis was used to assess the association between gene expression and vitamin D status adjusting 
for age, parity, menstrual cycle, personal history of ULM, hypertension and diabetes mellitus, BMI. P value < 0, 
05 defined the level of statistical significance. 
3. Results 
Data are expressed as mean ± standard deviation, absolute frequency (relative frequency in percent). 
Abbreviations: PH, personal history ULM; HT, hypertension; DM, diabetes mellitus; BMI, body mass index. p˂ 
0.05 
The table above shows that one hundred and five women were included in the present study; their mean age and 
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median vitamin D levels were 37.6 ± 7.5 years and 27.4 (24.8-27.3??) ng/ml, respectively. Nearly all of the 
patients were still having menses and more than half of them were nulliparous. Personal history of ULM, 
hypertension and diabetes was present in characterized 28.6%, 18.1% and 6.7% of patients, respectively. More 
than half of them had abnormal body weight with overweight and obesity observed in 35.2% and 21%, 
respectively.  
Apart from vitamin D levels, the differences observed in other variables of interest between the three subgroups 
did not reach the level of statistical significance.  
Table 2: General characteristics of the study population according to serum vitamin D status. 
Variable All 
n = 105 
 
Vitamin D status p 
Sufficient 
n = 41 
Insufficient 
n =36 
Deficiency 
n = 28 
Age, years 37.6 ± 7.5 36.5 ± 7.1 38.3 ± 8.7 38.0 ± 6.6 0.566 
Parity, n (%)      
  Null parity 58(55.2) 23(56.1) 21 (58;3) 14(50.0) 0.315 
  ≥1 47(44.8) 18(43.9) 15 (41.7) 14(50.0) 0.758 
Menstrual cycle, n (%)      
  Yes 104( 99 ) 41(100) 35(97.1) 28(100) 0.295 
  No   01( 1 ) - 1(2.8) -  
PH-ULM, n (%)      
  Yes 30(28.6) 15(36.6) 10(27.8) 5(17.9) 0.082 
  No  75(71.4) 26(63.4) 26(72.2) 23(82.1) 0.887 
PH-HT, n (%)      
  Yes 19(18.1) 7(17.1) 6(16.7) 6(21.4) 0.949 
  No 86(81.9) 34(82.9) 30(83.3) 22(78.6) 0.272 
PH-DM, n (%)      
  Yes   7(6.7) 3(7.3) 1(2.8) 3(10.7) 0.565 
  No 98(93.3) 38(92.7) 35(97.2) 25(89.3) 0.242 
BMI, Kg/m² 19.3 ± 7.7 26.4 ± 4.4  26.8± 5.4  25.1± 4.1  0.356 
  Normal, n (%) 46(43.8) 18(43.9) 15 (41.7) 13(46.4) 0.662 
  Overweight, n (%) 37(35.2) 13(31.7) 12(33.3) 12(42.3) 0.973 
  Obesity, n (%) 22(21) 10(24.4) 9(25) 3(10.7) 0.142 
Serum 250HD, ng/ml 27.4 
(24.8-29.9)  
16,50 
(16.0-18.5) 
9.00  
(7.0-11.0) 
2.50 
(2.0-3.0) 
<0.0001 
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Table 3: Gene expression of apoptotic markers Bcl2, Bax and of EBV infection marker LMP1 in uterine 
leiomyoma according to serum vitamin D status. 
Variable All 
n = 105 
 
Vitamin D status p 
Sufficient 
n = 41 
Insufficient 
n = 36 
Deficiency 
n = 28 
Bcl2 expression, n (%)      
 Positive:    Low  35(33.3)  12(29.3) 12(33.3) 11(39.3) 0.972 
                   Moderate 34(32.4) 15(36.6) 12(33.3) 7(25.0) 0.237 
                   High 27(25.7) 10(24.4) 10(27.8) 7(25.0) 0.717 
Negative 9(8.6) 4(9.8) 2(5.6) 3(10.7) 0.717 
Bax expression n (%)       
 Positive:    Low  4(3.8) 3(7.3) - 1(3.6) 0.617 
                   Moderate 4(3.8) 2(4.9) 1(2.8) 1(3.6) 0.779 
                   High 2(1.9) 1(2.4) 1(2.8) - 0.480 
Negative 95(90.5) 35(85.4) 34(94.4) 26(92.9) 0.464 
LMP1 expression n (%)      
                  Yes 30(28.6) 15(36.6) 5(13.9) 10(35.7) 0.082 
                  No 75(71.4) 26(63.4) 31(86.1) 18(64.3) 0.180 
 Abbreviations: Bcl, B cell lymphoma; Bax, B cell associated X protein; LMP1, lymph membrane protein 1. P˂ 
0.05. 
According to the table 3, of the 105 leiomyoma tissue examined, Bcl2 was expressed in 96 (91.4%) of samples 
with low, moderate and high expression observed in 33.3%, 32.4% and 25.7%, respectively. The differences in 
Bcl2 expression between the three subgroups of vitamin D categories were not statistically significant. 
As a mirror of Bcl2 expression, Bax protein was not expressed in the majority (n = 95, 90.5%) of samples. 
Similar to Bcl2, the differences in Bax expression between the three subgroups of vitamin D categories did not 
reach the level of statistical significance. 
Of the 105 leiomyoma tissue examined, LMP1 was observed in 30 (28.6%) of samples and showed a tendency 
towards increased expression with the decline in vitamin D levels; however, the tendency was fairly not 
statistically significant. 
The result on the table 4 shows that in multivariate analysis, predictors of Bcl2 expression were age, parity, 
overweight/obesity and insufficiency/deficiency; however, the differences observed were not statistically 
significant (Data not shown). The same predictors were also associated with Bax expression but once again the 
observed differences were not statistically significant (Data not shown). Vitamin D deficiency, the only 
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predictor significantly associated with LMP1 expression, conferred a 3.9 fold greater risk (aOR 3.9; 95% CI 
1.068-14.242; p = 0.039) of expressing LMP1 in leiomyoma tissue (Table 4).  
Table 4: Multivariate determinants of LMP1 expression among the study population. 
VARIABLES 
 
aOR CI95% p 
Age (years) 
 
2,079 0,666-6,493 0.208 
Parity 
 
1,147 0,444-2,964 0,777 
Menstrual cycle 
 
NS NS NS 
PH- ULM 
 
0.552 0,193-1,580 0.268 
PH-ULM 
 
0.989 0,303-3,222 0.985 
PH -MD 
 
0.607 0.114-3,231 0.559 
BMI 1 
 
- - 
Overweigh 
 
0,653 0,176-2,415 0.523 
Obesity 
 
1,703 0,426-6,808 0,451 
Vitamin  D 
 
1 - - 
Insufficiency 
 
1,004 0,335-3,011 0,994 
Deficiency 
 
3,900 1,068-14,242 0,039 
 Abbreviations: FH-ULM, familial history of uterine leiomyoma; PH-ULM, personal history of uterine 
leiomyoma; PH-MD, personal history of diabetes mellitus. 
4.  Discussion  
The present study has concerned the patients whose average age is 37.56 ± 7,548 years. Bang et al.  (21), 
Okogbo et al. (22) respectively have found 34.9 ±5.3 years and 39.4± 7.3 years. Recently Cham et al. (23) and 
Muhindo (24) have found 34.5 ± 7.5 years and 35.3 ± 4,9ans. These results comparable to each other is an 
argument which confirms the opinion according to which the uterine leiomyomas is a pathology of the elderly 
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woman of childbearing age.  
The Low Parity (average: 2.49 ± 1,804) and the Overweight (41.5%) as well as Obesity (21.0%) which 
predominate in these patients corroborate the high levels of risk always charged to these two factors (25, 26). 
A single case of menopause has been obseved. It is a patient aged 55years.This case shows the importance of 
sex hormonal excitations in the birthness and growth of uterine leiomyomas (27).            
The anti-apoptotic protein Bcl-2 was more expressed in ULM tissues than the pro apoptotic protein Bax in the 
present study. This finding agrees with results of previous reports on gene expression in human ULM tissues 
(28, 29, 30, 31). Using RT-PCR technique in case control study, Csatlos et al (28) found that Bcl2 gene was 
overexpressed in leiomyoma group compared with the control group although there was not such a difference in 
the gene expression of Bax. They concluded that the overexpression of the anti-apoptotic Bcl-2 gene appeared to 
be an important factor in the development of ULM whereas the pro apoptotic Bax gene did not seem to play a 
substantial role in the process. A similar finding was reported by Dixon et al (30) who found an altered 
apoptosis by overexpression of Bcl2 and decreased expression of Bax in human ULM tissues. While it is 
thought that the initial events that trigger leiomyoma tumor genesis involve somatic mutations, it is evident that 
the development and growth of ULM depends on ovarian steroid hormones (32, 33).  Although the evidence 
points to the role of these hormones, progesterone in particular plays a major role in ULM development and 
growth (32; 33). Studies have shown that progesterone can increase the expression of the anti-apoptotic Bcl-2 
gene (33, 34). Indeed, direct binding of liganded progesterone receptor to Bcl-2 promoter enhances its 
transcription in primary leiomyoma cells (32, 33).  
Bcl-2 expression tended to increase with the decline in Vit D levels in the present study but this association did 
not reach the level of statistical significance. Although contradictory in appearance to findings from previous 
studies (16, 34), the observed lack of association between Vitamin D levels and Bcl-2 expression in ULM 
tissues could be due to methodological issues relating to the small sample used. Nevertheless, an association 
between Vitamin D levels and apoptosis regulating protein has been already reported (34),Indeed, Vitamin D 
has been reported to exert anti-apoptotic effects on ULM cells by controlling members of Bcl-2 protein family 
that consists of both anti-apoptotic proteins such as Bcl-2, Bcl-xl, and Bcl-w and pro-apoptotic including Bax, 
Bak and Bad (34). Antonsson et al (35) showed repression of Bcl-2 and Bcl-w in human leiomyoma cell upon 
treatment with Vitamin D. They concluded that the growth inhibitory effect of Vitamin D is also mediated by 
blocking the expression of anti-apoptotic Bcl-2 and Bcl-w genes (34). 
In addition, Vitamin D apoptosis inhibitory effect has been reported to rely upon the suppression of cathecol-O-
methytransferase (COMT) expression and activity in human ULM cells (34) COMT enzyme catalyzes the 
transfer of a methyl group from S adenosyl-methionine to one of the phenolic groups of a variety of cathecols 
including cathecolestrogens and cathecholamin neurotransmitters (34). COMT is known to convert the 
cathecolestrogens, 2- and 4-hydroxyestrogen, to 2- and 4-methoxyestrogen, respectively (34) 2-hydroxyestrogen 
can act as estrogen antagonists in a variety of cells including human myometrial and leiomyoma cells while their 
methylated counterpart, 2-methoxyestrogen, as estrogen antagonists  ( 34) Vitamin D has been reported to 
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reduce COMT mRNA and protein expression as well as the enzyme activity in human ULM cells( 34) 
Therefore, Vit D deficiency may be an important risk factor in growth and progression of ULM (34). 
    LMP1 expression was significantly associated with Vitamin D deficiency. Vitamin D has been implicated in 
the host defense against infection as immune modulator through down-regulation of the pro-inflammatory 
response (36). It also has antimicrobial effects by inducing activation of macrophages with subsequent 
production of IFNϒ (36). Therefore, Vitamin D deficiency and subsequent relative immune dysfunction could 
facilitate latent or reactivated EBV infection to trigger tumor genesis in ULM cells (37). The pathophysiological 
relationship and molecular mechanisms of EBV-mediated tumor genesis have not yet been fully elucidated. 
EBV-induced tumors expressed three EBV-encoded proteins with latent membrane protein-1 (LMP-1) as the 
central player in the tumor genesis process (37). LMP1, an EBV-encoded primary oncogene, functions as a viral 
mimic of TNF receptor (TNFR) family member, CD40 and engages in a number of signaling pathways that 
induce morphological and phenotypic alterations in epithelial cells (37). LMP1 has been also reported to up 
regulate epithelial-mesenchymal transition (EMT) with subsequent malignant transformation of epithelial cells 
(37). Other EBV-encoded proteins such as BarmHI-A rightward frame 1 (BART1) can modulate apoptosis and 
host immune mechanisms (37).  
The interpretation of the results of the present study should take in account of some limitations. First, the cross-
sectional design of the study precludes the establishment of causal or temporal relationship. Second, the small 
sample size could not allow much power to statistical tests to detect additional associations between variables of 
interest. Third, vitamin D levels were determined once with the risk of overestimation of values obtained given 
the variability characterizing biologic parameters.  
5. Conclusion 
In the present study, Bcl2 gene expression in ULM tissues tended to increase with the decline in vitamin D 
levels but observed differences were not statistically significant. In contrast, LMP1 gene expression was 
significantly associated with vitamin D deficiency. In spite of methodological limits, these findings do suggest a 
role of Vitamin D deficiency in the development and progression of ULM. 
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